-
Yang Sheng meets with delegation of Egyptian Drug Authority
2026-09-30
Yang Sheng, deputy commissioner of China's National Medical Products Administration (NMPA), met with a delegation from the Egyptian Drug Authority (EDA) on Sept 28 in Beijing.
-
Lei Ping meets with chief executive of Malaysia’s Medical Device Authority
2026-09-30
Lei Ping, deputy commissioner of China's National Medical Products Administration (NMPA), met with Muralitharan Paramasua, chief executive of the Medical Device Authority of Malaysia, on Sept 22 in Beijing.
-
Huang Guo meets with president of Global Health at Gates Foundation
2026-09-23
Huang Guo, commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Trevor Mundel, president of Global Health at the Gates Foundation, on Sept 15 in Beijing.
-
NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance
2026-07-10
The National Medical Products Administration (NMPA) conducted its 2025 annual management review of the Quality Management System (QMS) for regulation of vaccine and drug Good Manufacturing Practice (GMP) compliance on June 30. NMPA Commissioner Huang Guo presided over the meeting and fully affirmed the suitability, adequacy and effectiveness of the NMPA's QMS in both areas.
-
NMPA holds meeting on vaccine regulatory QMS
2026-06-29
To advance the development of China's National Regulatory Authority (NRA) for vaccines and further enhance the country's vaccine regulatory capacity, the National Medical Products Administration (NMPA) held a working meeting on the development of the vaccine regulatory quality management system (QMS) in Changzhou, Jiangsu province, on June 12.
-
Yang Sheng meets with Danish ambassador and chairman of Novo Nordisk
2026-06-17
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), held talks with Michael Christensen, Denmark's ambassador to China, and Lars Sorensen, chairman of Danish global pharma group Novo Nordisk, on June 15 in Beijing.
